A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer - Related Studies

Home

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

This study has been completed.

Study NCT00036543. Last updated on August 10, 2006. Information provided by Abbott

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Prostate Cancer

2	Additional conditions recognized in this trial
		Prostatic Neoplasms

3	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		Atrasentan

5	Sponsors listed in this trial
		Abbott